Your browser doesn't support javascript.
Nanotechnology Solution for Early Detection of Micrometastatic Prostate Cancer After Radical Prostatectomy
NTIS; 2020.
Non-conventional in English | NTIS | ID: grc-753745
ABSTRACT
The overall objective of this research proposal is to conduct the initial development of a rapid circulating tumor cell-based blood test that can identify men with micrometastatic disease in order to facilitate patient selection for salvage radiotherapy. Aim 1 of this study was do perform a technical validation study and Aim 2 to embark upon testing of banked clinical specimens then to test the new assay in the setting of the NRG-GU-006 clinical trial (salvage radiotherapy /- apalutamide). In the first year of work we have begun a series of key technical validation studies while completing the sample collection from the now fully accrued NRG-GU-006 trial. Due to COVID-19 there were delays in progress but due to rapid clinical accrual and regearing of our studies, this effort is still on time.
Keywords

Full text: Available Collection: Databases of international organizations Database: NTIS Type of study: Prognostic study / Randomized controlled trials Language: English Year: 2020 Document Type: Non-conventional

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: Databases of international organizations Database: NTIS Type of study: Prognostic study / Randomized controlled trials Language: English Year: 2020 Document Type: Non-conventional